SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
23 04 2021
Historique:
received: 21 12 2020
accepted: 01 04 2021
pubmed: 24 4 2021
medline: 14 5 2021
entrez: 23 4 2021
Statut: epublish

Résumé

Many enveloped viruses induce multinucleated cells (syncytia), reflective of membrane fusion events caused by the same machinery that underlies viral entry. These syncytia are thought to facilitate replication and evasion of the host immune response. Here, we report that co-culture of human cells expressing the receptor ACE2 with cells expressing SARS-CoV-2 spike, results in synapse-like intercellular contacts that initiate cell-cell fusion, producing syncytia resembling those we identify in lungs of COVID-19 patients. To assess the mechanism of spike/ACE2-driven membrane fusion, we developed a microscopy-based, cell-cell fusion assay to screen ~6000 drugs and >30 spike variants. Together with quantitative cell biology approaches, the screen reveals an essential role for biophysical aspects of the membrane, particularly cholesterol-rich regions, in spike-mediated fusion, which extends to replication-competent SARS-CoV-2 isolates. Our findings potentially provide a molecular basis for positive outcomes reported in COVID-19 patients taking statins and suggest new strategies for therapeutics targeting the membrane of SARS-CoV-2 and other fusogenic viruses.

Identifiants

pubmed: 33890572
doi: 10.7554/eLife.65962
pii: 65962
pmc: PMC8104966
doi:
pii:

Substances chimiques

Membrane Lipids 0
Cholesterol 97C5T2UQ7J
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : GM134949
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL122531
Pays : United States
Organisme : Howard Hughes Medical Institute
ID : Investigator lab
Pays : United States
Organisme : NIGMS NIH HHS
ID : GM120351
Pays : United States
Organisme : NIGMS NIH HHS
ID : GM095467
Pays : United States
Organisme : NIGMS NIH HHS
ID : GM124072
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM134949
Pays : United States
Organisme : NIAID NIH HHS
ID : U24 AI118656
Pays : United States

Informations de copyright

© 2021, Sanders et al.

Déclaration de conflit d'intérêts

DS, CJ, PA, DB, AD, HK, DK, IC, SS, TT, AT, MS, AP, IL, FD, RP, BL No competing interests declared, AH ASH is a consultant for Dewpoint Therapeutics. CB CPB is a scientific founder and consultant for Nereid Therapeutics.

Références

Science. 1996 Apr 5;272(5258):115-7
pubmed: 8600520
Nature. 2020 Dec;588(7838):498-502
pubmed: 32805734
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Biophys J. 1983 Jan;41(1):95-7
pubmed: 6824758
Cell Metab. 2020 Aug 4;32(2):176-187.e4
pubmed: 32592657
J Biomol Screen. 1999;4(2):67-73
pubmed: 10838414
Science. 2017 Apr 21;356(6335):323-327
pubmed: 28386024
Sci Transl Med. 2020 Nov 4;12(568):
pubmed: 33077678
J Phys Chem B. 2019 Dec 19;123(50):10654-10662
pubmed: 31743644
EBioMedicine. 2020 Nov;61:103104
pubmed: 33158808
Nat Commun. 2020 Jan 9;11(1):152
pubmed: 31919352
Methods Mol Biol. 2019;1949:153-163
pubmed: 30790255
Nat Commun. 2017 Aug 29;8(1):370
pubmed: 28851864
Biochemistry. 1983 Jul 5;22(14):3466-74
pubmed: 6225455
Biophys J. 2003 Nov;85(5):3074-83
pubmed: 14581208
Biochem J. 2009 Nov 11;424(2):163-7
pubmed: 19811449
Chem Biol. 2013 Jul 25;20(7):912-21
pubmed: 23890009
Biochem Soc Trans. 2013 Feb 1;41(1):43-9
pubmed: 23356256
Cell Rep. 2021 Apr 6;35(1):108959
pubmed: 33811811
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11411-6
pubmed: 21709267
Cell Res. 2020 Apr;30(4):343-355
pubmed: 32231345
Virol J. 2009 Dec 24;6:230
pubmed: 20034394
Chest. 2021 Jan;159(1):85-92
pubmed: 33065103
Curr Protoc Cytom. 2012 Oct;Chapter 2:Unit2.19
pubmed: 23042527
J Cell Sci. 2019 Sep 16;132(18):
pubmed: 31527149
Anesthesiol Res Pract. 2013;2013:297141
pubmed: 24174934
J Biol Chem. 2009 Nov 20;284(47):32680-5
pubmed: 19783660
Viruses. 2020 Jun 10;12(6):
pubmed: 32532085
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
J Cell Sci. 2008 Nov 1;121(Pt 21):3619-28
pubmed: 18946025
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
PLoS Pathog. 2020 Aug 21;16(8):e1008762
pubmed: 32822426
FEBS Lett. 2006 Feb 20;580(5):1365-70
pubmed: 16455081
PLoS Pathog. 2021 Jan 25;17(1):e1009246
pubmed: 33493182
Methods Mol Biol. 2007;398:59-72
pubmed: 18214374
Nat Med. 2021 Apr;27(4):622-625
pubmed: 33654292
Proc Natl Acad Sci U S A. 2010 Dec 21;107(51):22050-4
pubmed: 21131568
Front Immunol. 2018 Jan 19;8:2003
pubmed: 29403483
Elife. 2019 Oct 30;8:
pubmed: 31657721
Nat Commun. 2020 Nov 18;11(1):5885
pubmed: 33208793
Mol Cell Biol. 2003 Jun;23(12):4267-82
pubmed: 12773569
Proc Natl Acad Sci U S A. 2021 Jan 5;118(1):
pubmed: 33443166
Mol Pharmacol. 2018 Apr;93(4):251-258
pubmed: 29298813
Nature. 2005 Sep 1;437(7055):154-8
pubmed: 16136145
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Nature. 2009 Feb 12;457(7231):882-6
pubmed: 19182773
Proc Natl Acad Sci U S A. 2018 Sep 4;115(36):E8499-E8508
pubmed: 30127022
Nat Rev Microbiol. 2021 Mar;19(3):155-170
pubmed: 33116300
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
Cell Res. 2020 Nov;30(11):1043-1045
pubmed: 32811977
Nature. 2003 Nov 27;426(6965):450-4
pubmed: 14647384
J Cell Biol. 2015 Mar 16;208(6):703-11
pubmed: 25753034
Virology. 2006 Jun 5;349(2):264-75
pubmed: 16507314
Trends Microbiol. 2014 Dec;22(12):715-24
pubmed: 25245455
J Virol. 2012 Jun;86(12):6537-45
pubmed: 22496216
Histopathology. 2020 Aug;77(2):198-209
pubmed: 32364264
Chem Sci. 2018 Feb 28;9(8):2340-2347
pubmed: 29520318
Methods Mol Biol. 2015;1232:65-77
pubmed: 25331128
Proc Int Conf Intell Syst Mol Biol. 1998;6:175-82
pubmed: 9783223
Elife. 2017 Feb 01;6:
pubmed: 28145867
Viruses. 2012 Jun;4(6):1011-33
pubmed: 22816037
Mol Pharmacol. 2013 Jul;84(1):86-94
pubmed: 23604141
J Am Chem Soc. 2013 May 15;135(19):7082-5
pubmed: 23631516
Molecules. 2015 Oct 16;20(10):18923-66
pubmed: 26501254
EMBO J. 2020 Nov 2;39(21):e106057
pubmed: 32944968
Biochim Biophys Acta. 2005 Dec 30;1746(3):295-304
pubmed: 16126288
Elife. 2014 Jun 11;3:
pubmed: 24920391
Nat Protoc. 2012 May 03;7(6):1042-51
pubmed: 22555243
J Cell Sci. 2013 Feb 15;126(Pt 4):966-77
pubmed: 23239027
Neuron. 2014 Jun 18;82(6):1271-88
pubmed: 24857020
J Virol. 2017 Oct 13;91(21):
pubmed: 28794042
Biophys J. 2006 Oct 1;91(7):2508-16
pubmed: 16829556
Cell. 2015 Mar 26;161(1):161-172
pubmed: 25815993
Elife. 2020 May 22;9:
pubmed: 32441254
Virus Res. 2012 Apr;165(1):112-7
pubmed: 22349148
J Mol Biol. 2004 May 14;338(5):1027-36
pubmed: 15111065
Biochim Biophys Acta. 2005 Dec 30;1746(3):172-85
pubmed: 16043244
Sci Rep. 2016 Jul 19;6:29842
pubmed: 27431907
Antiviral Res. 2018 Aug;156:55-63
pubmed: 29807040
J Cell Sci. 1997 Aug;110 ( Pt 15):1741-50
pubmed: 9264461
Nat Protoc. 2007;2(7):1573-84
pubmed: 17585299
Front Immunol. 2020 Oct 07;11:576622
pubmed: 33117378
Biochem Biophys Res Commun. 2008 Jul 4;371(3):356-60
pubmed: 18424264
PLoS Pathog. 2017 Feb 2;13(2):e1006099
pubmed: 28152024
J Virol. 2007 Mar;81(5):2418-28
pubmed: 17166901
Biochim Biophys Acta. 2013 Feb;1828(2):864-76
pubmed: 22989724
ACS Chem Biol. 2008 May 16;3(5):287-93
pubmed: 18484709
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6532-6539
pubmed: 27550352
Cell. 2020 Aug 6;182(3):685-712.e19
pubmed: 32645325
Mod Pathol. 2007 Jan;20(1):108-19
pubmed: 17143259
Elife. 2019 Sep 05;8:
pubmed: 31486771
Cell. 2019 Feb 21;176(5):1040-1053.e17
pubmed: 30712872
Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):11950-11955
pubmed: 29078404
PLoS Pathog. 2018 Dec 10;14(12):e1007471
pubmed: 30532200
Mol Oncol. 2013 Dec;7(6):1012-8
pubmed: 23916134
Antiviral Res. 2015 Apr;116:76-84
pubmed: 25666761
Cell. 2020 Apr 16;181(2):306-324.e28
pubmed: 32302570
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Curr Opin Cell Biol. 2003 Aug;15(4):414-22
pubmed: 12892781
J Virol. 2010 Feb;84(4):1891-901
pubmed: 20007283
Nat Commun. 2021 Sep 9;12(1):5333
pubmed: 34504087
Antiviral Res. 2020 Jun;178:104787
pubmed: 32251768
Proc Natl Acad Sci U S A. 2020 Aug 25;117(34):20803-20813
pubmed: 32764148
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3165-70
pubmed: 17360623
Virology. 2007 Apr 10;360(2):264-74
pubmed: 17134730
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1147-1152
pubmed: 28096411
Science. 2020 May 29;368(6494):1012-1015
pubmed: 32303590
Mol Syst Biol. 2011 Nov 08;7:549
pubmed: 22068332
PLoS One. 2021 Sep 10;16(9):e0257051
pubmed: 34506535
J Biol Chem. 2020 Mar 27;295(13):4289-4302
pubmed: 32079676
Biophys J. 2017 Sep 19;113(6):1200-1211
pubmed: 28801104
Curr Opin Neurobiol. 2019 Aug;57:9-16
pubmed: 30677713
J Med Chem. 2013 Mar 14;56(5):1789-95
pubmed: 23356819
ACS Pharmacol Transl Sci. 2020 Oct 19;3(6):1165-1175
pubmed: 33330839
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Trends Endocrinol Metab. 2017 Jun;28(6):461-472
pubmed: 28259375
J Med Virol. 2020 Oct;92(10):2087-2095
pubmed: 32374457
Nat Rev Cancer. 2007 Dec;7(12):968-76
pubmed: 18034186
Drug Metab Dispos. 2011 Jun;39(6):1070-8
pubmed: 21406602
Br J Ophthalmol. 1978 Jan;62(1):46-52
pubmed: 629910
ACS Chem Biol. 2017 Jan 20;12(1):174-182
pubmed: 28103683
J Virol. 2004 Mar;78(6):2682-92
pubmed: 14990688
Nucleic Acids Res. 2015 Jan;43(Database issue):D204-12
pubmed: 25348405
Biochem Biophys Res Commun. 2008 May 2;369(2):344-9
pubmed: 18279660
J Virol. 2019 Jul 17;93(15):
pubmed: 31118253
Nat Commun. 2020 Mar 27;11(1):1620
pubmed: 32221306
Biochim Biophys Acta. 2007 Jun;1768(6):1311-24
pubmed: 17493580
Microbes Infect. 2007 Jan;9(1):96-102
pubmed: 17194611
Nat Cell Biol. 2018 Jun;20(6):688-698
pubmed: 29802406
Virology. 2018 Apr;517:9-15
pubmed: 29217279
Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):89-94
pubmed: 27994139
J Virol. 2003 Aug;77(15):8237-48
pubmed: 12857892
Viruses. 2012 Apr;4(4):557-80
pubmed: 22590686
Biotechnol Bioeng. 2001 May 20;73(4):313-23
pubmed: 11283914
Virology. 1988 Apr;163(2):276-83
pubmed: 2833007
Cancer Immunol Res. 2014 Nov;2(11):1023-33
pubmed: 25367977
PLoS One. 2013 Sep 20;8(9):e75084
pubmed: 24073236
J Thorac Oncol. 2020 May;15(5):700-704
pubmed: 32114094
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9
pubmed: 25288733
Virology. 2010 Sep 15;405(1):139-48
pubmed: 20580052
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Antimicrob Agents Chemother. 2015 Feb;59(2):1088-99
pubmed: 25487801
Antimicrob Agents Chemother. 2020 May 21;64(6):
pubmed: 32312781
Proc Natl Acad Sci U S A. 2020 Dec 15;117(50):32105-32113
pubmed: 33239446
Biochemistry. 2003 Dec 16;42(49):14677-89
pubmed: 14661981
J Med Virol. 1991 Oct;35(2):142-9
pubmed: 1662706
J Med Virol. 2021 Mar;93(3):1320-1342
pubmed: 33073355
Biochemistry. 2015 Mar 10;54(9):1819-30
pubmed: 25668103
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Science. 2013 Apr 19;340(6130):359-63
pubmed: 23470732
Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4764-9
pubmed: 20176935
Trends Cell Biol. 2020 May;30(5):341-353
pubmed: 32302547
Biophys J. 2013 Dec 17;105(12):2751-9
pubmed: 24359747
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):E117-26
pubmed: 26715744
Chem Biol. 2014 Jan 16;21(1):97-113
pubmed: 24361047
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
EMBO J. 2020 Dec 1;39(23):e106267
pubmed: 33051876
Biochim Biophys Acta. 2008 Jan;1778(1):20-32
pubmed: 17936718
Nature. 1997 Jun 5;387(6633):569-72
pubmed: 9177342
J Phys Chem B. 2020 Jul 16;124(28):5930-5939
pubmed: 32436385
Am J Cardiol. 2020 Dec 1;136:149-155
pubmed: 32946859
Nature. 2020 Oct;586(7827):113-119
pubmed: 32707573
Nat Microbiol. 2020 Jul;5(7):929-942
pubmed: 32284563
Annu Rev Pharmacol Toxicol. 1984;24:43-64
pubmed: 6329077

Auteurs

David W Sanders (DW)

Department of Chemical and Biological Engineering, Princeton University, Princeton, United States.

Chanelle C Jumper (CC)

Department of Chemical and Biological Engineering, Princeton University, Princeton, United States.

Paul J Ackerman (PJ)

Department of Chemical and Biological Engineering, Princeton University, Princeton, United States.

Dan Bracha (D)

Department of Chemical and Biological Engineering, Princeton University, Princeton, United States.

Anita Donlic (A)

Department of Chemical and Biological Engineering, Princeton University, Princeton, United States.

Hahn Kim (H)

Princeton University Small Molecule Screening Center, Princeton University, Princeton, United States.
Department of Chemistry, Princeton University, Princeton, United States.

Devin Kenney (D)

Department of Microbiology, Boston University School of Medicine, Boston, United States.
National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.

Ivan Castello-Serrano (I)

Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, United States.

Saori Suzuki (S)

Department of Molecular Biology, Princeton University, Princeton, United States.

Tomokazu Tamura (T)

Department of Molecular Biology, Princeton University, Princeton, United States.

Alexander H Tavares (AH)

National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.
Department of Biochemistry, Boston University School of Medicine, Boston, United States.

Mohsan Saeed (M)

National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.
Department of Biochemistry, Boston University School of Medicine, Boston, United States.

Alex S Holehouse (AS)

Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, United States.

Alexander Ploss (A)

Department of Molecular Biology, Princeton University, Princeton, United States.

Ilya Levental (I)

Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, United States.

Florian Douam (F)

Department of Microbiology, Boston University School of Medicine, Boston, United States.
National Emerging Infectious Diseases Laboratories, Boston University, Boston, United States.

Robert F Padera (RF)

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, United States.

Bruce D Levy (BD)

Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, United States.

Clifford P Brangwynne (CP)

Department of Chemical and Biological Engineering, Princeton University, Princeton, United States.
Howard Hughes Medical Institute, Princeton, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH